R
Russell A. Higgins
Researcher at University of Texas Health Science Center at San Antonio
Publications - 26
Citations - 580
Russell A. Higgins is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Biopsy & Fluorescence in situ hybridization. The author has an hindex of 11, co-authored 24 publications receiving 494 citations. Previous affiliations of Russell A. Higgins include Baylor College of Medicine & College of American Pathologists.
Papers
More filters
Journal ArticleDOI
Anaplastic Large Cell Lymphoma: Twenty-Five Years of Discovery
TL;DR: Based on immunostaining for activation antigen CD30 and the presence of dysregulation of the anaplastic lymphoma kinase gene (2p23), the diagnosis of ALCL has become relatively straightforward for most patients and major strides have been made during the last decade in understanding of the complex pathogenesis ofALCL.
Journal ArticleDOI
Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma.
TL;DR: Immunophenotyping is required for the diagnosis and classification of lymphoid malignancies and some of the newer antibodies, particularly against transcription factors, that are diagnostically and prognostically useful are given.
Journal ArticleDOI
Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia
Shelly R. Gunn,Mansoor S. Mohammed,Mercedes E. Gorre,Philip D. Cotter,Jaeweon Kim,David W. Bahler,Sergey N. Preobrazhensky,Russell A. Higgins,Aswani R. Bolla,Sahar H. Ismail,Daphne de Jong,Eric Eldering,Marinus H. J. van Oers,Clemens Mellink,Michael J. Keating,Ellen J. Schlette,Lynne V. Abruzzo,Ryan S. Robetorye +17 more
TL;DR: Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL and is the most commonly identified alteration of prognostic significance.
Journal ArticleDOI
D-dimer: Simple test, tough problems
TL;DR: There is considerable variability both within and among quantitative methods used to assay D-dimer by laboratories, and laboratory practice continues to vary widely regarding the type and magnitude of units reported and the setting of the threshold for the exclusion of VTE.
Journal ArticleDOI
A prospective rAnDomised study of a rotary powered device (OnControl) for Bone marrow aspiration and biopsy
Ronan T. Swords,Javier Anguita,Russell A. Higgins,Andrea C. Yunes,Michael C. Naski,Swaminathan Padmanabhan,Kevin R. Kelly,Devalingam Mahalingam,Thomas Philbeck,Larry J. Miller,Tatiana Puga,Francis J. Giles,Marsha C. Kinney,Andrew Brenner +13 more
TL;DR: The use of a powered bone marrow biopsy device significantly reduces needle insertion pain and procedural time when compared to a manual technique, and the superior size and overall quality of core specimens retrieved by the powered device provides more material for pathologic evaluation.